Search research articles
Contact Us
Filters
Showing results (1101-1110 of 1,518) with videos related to
Page
of 152
Sort By:
Genome Research
|
October 20, 2012
Pluripotent stem cells escape from senescence-associated DNA methylation changes
Carmen M Koch, Kristina Reck, Kaifeng Shao, et al.
Veterinary Parasitology
|
September 7, 2025
Standardization of larval bioassays for determination of fluralaner susceptibility in Rhipicephalus microplus
Guilherme Klafke, Jorgelina Torrents, Priscila Teixeira Ferreira, et al.
Frontiers in Psychiatry
|
June 28, 2024
Facial emotion recognition in children of parents with a mental illness
Naomi Leona Werkmann, Arleta Angelika Luczejko, Klara Hagelweide, et al.
Medical and Veterinary Entomology
|
October 15, 2024
Prevalence of and potential risk factors for multiple resistance to acaricides in Rhipicephalus (Boophilus) microplus ticks: A survey in the state of Rio Grande Do Sul, Brazil
Priscila Teixeira Ferreira, Nathalia de Bem Bidone, Fernando Groff, et al.
Cadernos De Saude Publica
|
October 18, 2000
[Women caring for women: a study at the "Viva Maria" shelter, Porto Alegre, Rio Grande do Sul, Brazil]
S N Meneghel, M Camargo, L R Fasolo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2008
A phase II pharmacodynamic study of erlotinib in patients with advanced non-small cell lung cancer previously treated with platinum-based chemotherapy
Enriqueta Felip, Federico Rojo, Martin Reck, et al.
Advances in Therapy
|
March 2, 2025
Patient-Reported Outcomes for Patients with Previously Treated Small Cell Lung Cancer Receiving Tarlatamab: Results from the DeLLphi-301 Phase 2 Trial
Horst-Dieter Hummel, Myung-Ju Ahn, Fiona Blackhall, et al.
Clinical Lung Cancer
|
July 11, 2017
LUME-Meso: Design and Rationale of the Phase III Part of a Placebo-Controlled Study of Nintedanib and Pemetrexed/Cisplatin Followed by Maintenance Nintedanib in Patients With Unresectable Malignant Pleural Mesothelioma
Giorgio V Scagliotti, Rabab Gaafar, Anna K Nowak, et al.
Journal of Hepatology
|
December 15, 2010
Association of the hemochromatosis gene with pazopanib-induced transaminase elevation in renal cell carcinoma
Chun-Fang Xu, Brian H Reck, Vicki L Goodman, et al.
Therapeutic Advances in Medical Oncology
|
May 17, 2021
Afatinib as first-line treatment in patients with <i>EGFR</i>-mutated non-small cell lung cancer in routine clinical practice
Wolfgang M Brückl, Martin Reck, Frank Griesinger, et al.
Page
of 152
Search research articles
Search
Showing results (1101-1110 of 1,518) with videos related to
Sort By:
Page
of 152
Genome Research
|
October 20, 2012
Pluripotent stem cells escape from senescence-associated DNA methylation changes
Carmen M Koch, Kristina Reck, Kaifeng Shao, et al.
Veterinary Parasitology
|
September 7, 2025
Standardization of larval bioassays for determination of fluralaner susceptibility in Rhipicephalus microplus
Guilherme Klafke, Jorgelina Torrents, Priscila Teixeira Ferreira, et al.
Frontiers in Psychiatry
|
June 28, 2024
Facial emotion recognition in children of parents with a mental illness
Naomi Leona Werkmann, Arleta Angelika Luczejko, Klara Hagelweide, et al.
Medical and Veterinary Entomology
|
October 15, 2024
Prevalence of and potential risk factors for multiple resistance to acaricides in Rhipicephalus (Boophilus) microplus ticks: A survey in the state of Rio Grande Do Sul, Brazil
Priscila Teixeira Ferreira, Nathalia de Bem Bidone, Fernando Groff, et al.
Cadernos De Saude Publica
|
October 18, 2000
[Women caring for women: a study at the "Viva Maria" shelter, Porto Alegre, Rio Grande do Sul, Brazil]
S N Meneghel, M Camargo, L R Fasolo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2008
A phase II pharmacodynamic study of erlotinib in patients with advanced non-small cell lung cancer previously treated with platinum-based chemotherapy
Enriqueta Felip, Federico Rojo, Martin Reck, et al.
Advances in Therapy
|
March 2, 2025
Patient-Reported Outcomes for Patients with Previously Treated Small Cell Lung Cancer Receiving Tarlatamab: Results from the DeLLphi-301 Phase 2 Trial
Horst-Dieter Hummel, Myung-Ju Ahn, Fiona Blackhall, et al.
Clinical Lung Cancer
|
July 11, 2017
LUME-Meso: Design and Rationale of the Phase III Part of a Placebo-Controlled Study of Nintedanib and Pemetrexed/Cisplatin Followed by Maintenance Nintedanib in Patients With Unresectable Malignant Pleural Mesothelioma
Giorgio V Scagliotti, Rabab Gaafar, Anna K Nowak, et al.
Journal of Hepatology
|
December 15, 2010
Association of the hemochromatosis gene with pazopanib-induced transaminase elevation in renal cell carcinoma
Chun-Fang Xu, Brian H Reck, Vicki L Goodman, et al.
Therapeutic Advances in Medical Oncology
|
May 17, 2021
Afatinib as first-line treatment in patients with <i>EGFR</i>-mutated non-small cell lung cancer in routine clinical practice
Wolfgang M Brückl, Martin Reck, Frank Griesinger, et al.
Page
of 152